Rationale for growth hormone therapy in children with chronic kidney disease

Larry A. Greenbaum, Marcela Del Rio, Fatai Bamgbola, Frederick Kaskel

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Growth retardation is a common complication in children with chronic kidney disease. Treatable causes of growth retardation in these patients include renal osteodystrophy, metabolic acidosis, and inadequate nutritional intake. In addition, disturbances in the growth hormone-insulinlike growth factor I axis are a major cause of decreased growth. Administration of recombinant human growth hormone can overcome this problem, allowing catch-up growth and achievement of normal or improved adult height.

Original languageEnglish (US)
Pages (from-to)377-386
Number of pages10
JournalAdvances in Chronic Kidney Disease
Issue number4
StatePublished - Oct 2004


  • Chronic kidney disease
  • IGF-I
  • growth failure
  • recombinant human growth hormone

ASJC Scopus subject areas

  • Nephrology


Dive into the research topics of 'Rationale for growth hormone therapy in children with chronic kidney disease'. Together they form a unique fingerprint.

Cite this